Table 5. Logistic regression models predicting pathologic psychometric scores (OR; p value [95%CI]) in the whole cohort (Model A; No. = 297) and only in women with rUTIs (Model B; No. = 147).
Pathologic FSFI | Pathologic SDS |
Pathologic FSFI |
Pathologic SDS |
|||||
---|---|---|---|---|---|---|---|---|
UVA | MVA | UVA | MVA | UVA | MVA | UVA | MVA | |
Model A | Model B | |||||||
Age | 1.3; <0.001 [1.06–1.2] | 1.10; 0.03 [1.05–1.15] | 1.16; <0.002 [1.08–1.24] | 1.08; 0.025 [1.01–1.17] | 1.3; <0.001 [1.06–1.2] | 1.22; 0.009 [1.05–1.4] | 1.16; <0.002 [1.08–1.24] | 1.15; 0.021 [1.02–1.3] |
BMI | 1.05; 0.40 [0.93–1.2] | 1.06; 0.44 [0.96–1.24] | 1.01; 0.76 [0.9–1.14] | 1.01; 0.89 [0.86–1.18] | 1.05; 0.40 [0.93–1.2] | 1.05; 0.65 [0.84–1.30] | 1.01; 0.76 [0.9–1.14] | 0.96; 0.66 [0.79–1.15] |
CCI ≥1 | 0.58; 0.36 [0.18–1.8] | 1.72; 0.53 [0.32–9.36] | 0.47; 0.53 [0.9–1.14] | 0.48; 0.38 [0.09–2.42] | 0.58; 0.36 [0.18–1.8] | 1.15; 0.91 [0.08–8.81] | 0.47; 0.53 [0.9–1.14] | 0.18; 1.21 [0.02–1.55] |
Tot IPSS | 1.2; <0.01 [1.08–1.3] | 1.10; 0.04 [1.02–1.2] | 1.26; <0.001 [1.14–1.3] | 1.2; 0.002 [1.06–1.30] | 1.2; <0.01 [1.08–1.3] | 1.21; 0.02 [1.02–1.4] | 1.26; <0.001 [1.14–1.3] | 1.2; 0.015 [1.04–1.41] |
+rUTIs | 13.7; <0.001 [4.86–8.5] | 7.69; <0.001 [2.49–7.78] | 12.83; <0.001 [4.58–13.9] | 5.68; 0.003 [1.77–18.16] | — | — | — | — |
— | — | — | — | |||||
No. of UTI episodes (over the prior 12 months) ≥6 vs.<6 | 6.2; 0.003 [1.9–20.3] | 9.3; 0.02 [1.32–6.2] | 7.31; <0.001 [2.38–22.3] | 6.8; 0.022 [1.31–5.30] | ||||
Constipation history Yes vs. No | 12.3; <0.001 [3.8–20.2] | 6.32; 0.03 [1.22–6.6] | 16.1; <0.001 [4.8–18.3] | 4.9; 0.04 [1.08–9.8] |
Keys: UVA = Univariable analyses; MVA = Multivariable analyses; CCI = Charlson Comorbidity Index; BMI = body mass index; +rUTIs = Positive for recurrent urinary tract infections.